Bob de Rooij

776 total citations
6 papers, 278 citations indexed

About

Bob de Rooij is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Bob de Rooij has authored 6 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Bob de Rooij's work include Immunotherapy and Immune Responses (2 papers), Dermatology and Skin Diseases (2 papers) and Antimicrobial Peptides and Activities (2 papers). Bob de Rooij is often cited by papers focused on Immunotherapy and Immune Responses (2 papers), Dermatology and Skin Diseases (2 papers) and Antimicrobial Peptides and Activities (2 papers). Bob de Rooij collaborates with scholars based in Netherlands, Switzerland and United Kingdom. Bob de Rooij's co-authors include Monique L. den Boer, Rob Pieters, Roel Polak, Geertje van der Horst, Petra G.M. van Overveld, Christel van den Hoogen, Rob C.M. Pelger, Hiu Wing Cheung, Jeroen T. Buijs and Gabri van der Pluijm and has published in prestigious journals such as Blood, Oncogene and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Bob de Rooij

6 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bob de Rooij Netherlands	4	151	80	52	36	32	6	278
John P. Maufort United States	8	271 1.8×	88 1.1×	58 1.1×	40 1.1×	38 1.2×	12	487
Erik W. Martin United States	11	124 0.8×	37 0.5×	72 1.4×	72 2.0×	23 0.7×	16	323
Katharina Mandel Germany	8	180 1.2×	123 1.5×	12 0.2×	57 1.6×	73 2.3×	10	343
Stephen Proctor United Kingdom	6	150 1.0×	176 2.2×	48 0.9×	29 0.8×	25 0.8×	12	366
Chia Ching Chan United States	5	329 2.2×	37 0.5×	49 0.9×	56 1.6×	13 0.4×	8	474
Farha H. Vasanwala United States	8	249 1.6×	112 1.4×	16 0.3×	41 1.1×	34 1.1×	9	459
Karin M. Gilljam Norway	9	397 2.6×	104 1.3×	13 0.3×	42 1.2×	10 0.3×	11	475
Michaela Schneider Germany	7	274 1.8×	53 0.7×	110 2.1×	55 1.5×	20 0.6×	14	379
Stacey L. Fanning United States	5	123 0.8×	33 0.4×	25 0.5×	32 0.9×	15 0.5×	9	326
Flávio Henrique Paraguassú-Braga Brazil	6	129 0.9×	28 0.3×	48 0.9×	11 0.3×	79 2.5×	9	292

Countries citing papers authored by Bob de Rooij

Since Specialization

Citations

This map shows the geographic impact of Bob de Rooij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bob de Rooij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bob de Rooij more than expected).

Fields of papers citing papers by Bob de Rooij

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bob de Rooij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bob de Rooij. The network helps show where Bob de Rooij may publish in the future.

Co-authorship network of co-authors of Bob de Rooij

This figure shows the co-authorship network connecting the top 25 collaborators of Bob de Rooij. A scholar is included among the top collaborators of Bob de Rooij based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bob de Rooij. Bob de Rooij is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Wilkinson, Holly N., Michelle Rudden, Nina Dias Coelho-Rocha, et al.. (2024). Selective Depletion of Staphylococcus aureus Restores the Skin Microbiome and Accelerates Tissue Repair after Injury. Journal of Investigative Dermatology. 144(8). 1865–1876.e3. 9 indexed citations

2.

Méloni, Marisa, et al.. (2024). Targeted Antibacterial Endolysin to Treat Infected Wounds on 3D Full-Thickness Skin Model: XZ.700 Efficacy. Pharmaceutics. 16(12). 1539–1539. 1 indexed citations

3.

Eichenseher, Fritz, Bjorn L. Herpers, Juan Manuel Leyva-Castillo, et al.. (2022). Linker-Improved Chimeric Endolysin Selectively Kills Staphylococcus aureus In Vitro , on Reconstituted Human Epidermis, and in a Murine Model of Skin Infection. Antimicrobial Agents and Chemotherapy. 66(5). e0227321–e0227321. 31 indexed citations

4.

Rooij, Bob de, Roel Polak, Rob Pieters, & Monique L. den Boer. (2015). B-Cell Precursor Acute Lymphoblastic Leukemia Cells Create a Self-Reinforcing Niche Independent of the CXCR4/CXCL12 Axis. Blood. 126(23). 1297–1297. 1 indexed citations

5.

Polak, Roel, Bob de Rooij, Rob Pieters, & Monique L. den Boer. (2015). B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment. Blood. 126(21). 2404–2414. 137 indexed citations

6.

Buijs, Jeroen T., Geertje van der Horst, Christel van den Hoogen, et al.. (2011). The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation. Oncogene. 31(17). 2164–2174. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact